Table 2.

MVs in patients with cirrhosis with vs. without AKI at baseline.

MVs/uL	AKI (n = 40)	No AKI (n = 40)	P value
Calcein + MVs (total)	2108 (1652–2977)	1523 (947–1931)	0.002
ESelectin + MVs (endothelial)	1055 (677–1513)	563 (343–755)	<0.0001
PSelectin + MVs (platelet)	777 (535–1369)	425 (213–535)	<0.0001
TF + MVs	54 (34–140)	50 (31–80)	0.3
CD45 + MVs (leukocyte)	52 (32–141)	50 (23–76)	0.05
TM + MVs	728 (423–956)	665 (429–800)	0.3
Hepatocyte-MVs	27 (13–44)	32 (20–42)	0.6
ESelectin + TF + (endothelial-TF + )	85 (61–189)	75 (44–102)	0.1
PSelectin + TF + (platelet-TF + )	46 (22–108)	36 (10–60)	0.006
CD45 + TF + (leukocyte-TF +)	26 (10–62)	25 (7–40)	0.1

Median values reported with 25th and 75th percentiles in parenthesis.

MV: microvesicles; TF: Tissue factor; TM: thrombomodulin; Hep: hepatocyte; AKI: acute kidney injury.